-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622. Lymphomas: Translational–Non-Genetic: Poster III

Symposia: Lymphomas: Translational–Non-Genetic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Anthony Colombo, MS1*, Jia Yin Wan, M.S.2*, Aixiang Jiang, MS3*, Jose Aparicio4*, Esther Lam, MPH5*, Tomohiro Aoki, PhD, M.D6*, Joo Y Song, MD7*, Sheeja Pullarkat, MD8*, Chun Chao, M.D9*, Juan Manuel Mejia-Arangure10*, Brenda Hernandez11*, Pamela B. Allen, MD12, Christopher R. Flowers, MD, MS13, Sophia S. Wang, PhD14*, Juanita Evans15*, Owen Chan11*, Jakub Svoboda, MD16, Anja Mottok17*, Leon Bernal-Mizrachi, MD18, Megan Lim19*, David W. Scott, MBChB, PhD20, Imran Siddiqi, MD, PhD4*, David Conti21*, Christian Steidl, MD, PhD22 and Wendy Cozen, DO, MPH23

1Department of Population and Public Health Sciences, University of Southern California, Keck School of Medicine, Los Angeles, CA
2University of California, Irvine, Irvine, CA
3Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
4Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
5Department of Pathology and Laboratory Medicine, University of California Irvine, Orange, CA
6British Columbia Cancer, Vancouver, BC, Canada
7Department of Pathology, City of Hope National Medical Center, Duarte, CA
8Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
9Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA
10Instituto Nacional de Medicina Genomica & Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
11University of Hawai’i Cancer Center, University of Hawai'i, Honolulu, HI
12Department of Hematology, Emory University School of Medicine, Decatur, GA
13Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
14City of Hope, Duarte, CA
15Department of Pathology, Ascension Providence Southfield Hospital, Southfield, MO
16Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
17Department of Pathology, University of Giessen, University, Hesse, Germany
18Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
19Memorial Sloan Kettering Cancer Center, New York, NY
20Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
21Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA
22Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
23Division of Hematology, Department of Medicine, University of California Irvine, Orange, CA

Kylie Keijzer1*, Janneke W. de Boer2*, Jaap A. van Doesum2*, Walter Noordzij3*, Gerwin A. Huls, PhD4, Lisanne V. van Dijk5*, Tom van Meerten, MD, PhD2* and Anne G.H. Niezink5*

1Department of Hematology | Radiation Oncology, University Medical Center Groningen, Groningen, Netherlands
2Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
3Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands
4Department of Experimental Hematology, University Medical Center Groningen, Groningen, Netherlands
5Department of Radiation Oncology, University Medical Center Groningen, Groningen, Netherlands

Paul R Buckley, DPhil1*, Julie Chan, PhD2*, Laura Jouvin3*, Cynthia Bishop4*, Timothy Woo, MD5*, Katrina Todd6*, Elizabeth Phillips, MD7, Alessia Bottos, PhD8,9* and Piers EM Patten, FRCP, FRCPath, PhD10,11

1Guy's Cancer Centre, Comprehensive Cancer Centre, King's College London / GSTT, London, ENG, United Kingdom
2King's College London, London, United Kingdom
3Comprehensive Cancer Centre, King's College London / KCH, London, United Kingdom
4Guy's Hospital, Guy's & St Thomas NHS Foundation Trust, London, United Kingdom
5King's College London / KCH, London, United Kingdom
6Guy's & St Thomas NHS Foundation Trust, London, United Kingdom
7The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom
8F. Hoffmann-La Roche Ltd, Basel, Switzerland
9Roche, Basel, Switzerland
10Comprehensive Cancer Centre, King’s College London, London, GBR
11Department of Haematology, King’s College Hospital, London, GBR

Catherine S Diefenbach, MD1, Edgar Gonzalez-Kozlova2*, Diane Marie Del Valle2*, Hsin-Hui Huang2*, Opeyemi Jegede3*, Vanessa Barcessat4*, Kevin Tuballes4*, Geoffrey Kelly5*, Manishkumar Patel, MS6*, Hui Xie2*, Jocelyn Harris6*, Kimberly Argueta2*, Kai Nie2*, Radim Moravec7*, Jennifer Altreuter8*, Dzifa Yawa Duose9*, Brad S. Kahl, MD10, Stephen M Ansell, MD, PhD11, Joyce Yu12*, Ethan Cerami12*, James Lindsay12*, Ignacio Wistuba9*, Seunghee Kim-Schulze, PhD13* and Sacha Gnjatic14*

1Perlmutter Cancer Center at NYU Langone Health, New York, NY
2Icahn School of Medicine At Mount Sinai, New York, NY
3CIMAC-CIDC Network, Department of Data Science, Boston, MA
4Icahn School of Medicine At Mount Sinai, NEW YORK, NY
5Department of Immunology & Immunotherapy, Icahn School of Medicine At Mount Sinai, New York, NY
6Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY
7NIH-NCI, Rockville, MD
8Dana Farber Cancer Center, Department of Data Science, CIMAC-CIDC Network, Boston, MA
9Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX
10Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
11Division of Hematology, Mayo Clinic, Rochester, MN
12Dana-Farber Cancer Institute, Boston, MA
13Department of Immunology & Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY
14Icahn School of Medicine at Mount Sinai, New York, NY

Keri Toner, MD1, Hema Dave, MD, MPH2*, Gloria Pezzella3*, Qinglin Pei, PhD4*, Terzah M. Horton, MD, PhD5*, Kara M. Kelly, MD6, Lisa Giulino Roth, MD7, Sharon M. Castellino, MD, MSc8 and Catherine M. Bollard, MD9

1Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC
2Merck, North Wales, PA
3Children's National Hospital, Washington, DC
4COG Data Center, University of Florida College of Public Health & Health Professions and College, Gainesville, FL
5Baylor College of Medicine/Dan L. Duncan Cancer Center and Texas Children's Canc, Houston, TX
6Roswell Park Comprehensive Cancer Center, Buffalo, NY
7Weill Cornell Medicine, New York
8Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
9Children’s National Hospital, Washington, DC

Aurélie Dupuy1*, Laura Pelletier2*, Jerome Giustiniani3*, Peter Kim4*, Kamlesh Bisht, PhD4*, Hongfang Wang, PhD4*, Helgi J. Van de Velde, MD, PhD4, Corinne Haioun, MD, PhD5, Philippe Gaulard6* and Nicolas Ortonne7*

1Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, CRETEIL, France
2IMRB U955, CRETEIL, France
3Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, CRETEIL, France
4Sanofi R&D, North America, Cambridge, MA
5Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
6Department of Pathology and INSERM U955 Team 9, AP-HP, HôPital Henri-Mond, CréTeil, FRA
7Paris-Est Créteil University (UPEC), Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955 & Henri Mondor hospital, Department of Pathology, AP-HP, Creteil, FRA

Jianmin Han, MD PhD1*, Chad M McCall, MD, PhD2*, Scott Isom3*, Wesley Smith, DO4*, Dakota Jenneman, MD5*, Stephanie Begley, MS6*, Rupali Bose, MS, MBA6*, Mary Beth Seegars, MD7*, Eric D. Hsi, MD8 and Nilanjan Ghosh, MD, PhD9

1Atrium Health Wake Forest University School of Medicine, Winston-Salem, NC
2Carolinas Pathology Group, Charlotte, NC
3Wake Forest University School of Medicine, Winston-Salem, New Caledonia
4Wake Forest University School of Medicine, Winston-Salem, NC
5Atrium Health Levine Cancer Institute, Charlotte, NC
6Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
7Wake Forest University School of Medicine, Winston Salem, NC
8Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
9Levine Cancer Institute, Atrium Health, Charlotte, NC

Suvi-Katri Leivonen, PhD1, Kristiina Karihtala, MD2*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD3*, Teijo Pellinen, PhD4* and Sirpa Leppä, Professor5

1University of Helsinki, Helsinki, Finland
2Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
5Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Lixia Sheng*, Jiaping WANG*, Zhouning Lin*, Yanli Lai* and Guifang Ouyang*

The First Affiliated Hospital of Ningbo University, Ningbo, China

Bingyu Liu, MS1*, Shunfeng Hu2*, Zhuoya Yu3*, Tiange Lu3*, Mengfei Ding3*, Xiangxiang Zhou2* and Xin Wang, MD, PhD2,3

1Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan,Shandong, AL, China
2Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
3Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China

Camille Fong Chih Kai, MD, MSc1*, Bastien Lesne, MSc2*, Amandine Durand, MD1*, Mathilde Stephan1*, François Godard, MD3*, Daniela Lakomy, MD, PhD4*, Camille Guibert, MD5*, Laurent Martin, MD, PhD5,6*, Romain Aucagne, PhD6*, Laurent Delva, PhD6*, Cédric Rossi, MD, PhD1,6,7 and Rene-Olivier Casasnovas, MD1,6*

1Department of Hematology, University Hospital F. Mitterrand, Dijon, France
2LYSARC, Lyon, France
3Department of Nuclear medicine, Centre F. Leclerc, Dijon, France
4Department of Immunology, University Hospital F. Mitterrand, Dijon, France
5Department of Pathology, University Hospital F. Mitterrand, Dijon, France
6INSERM 1231, Dijon, France
7Stanford University, Stanford, CA

Akio Onishi, MD1*, Aya Miyagawa-Hayashino, MD, PhD2*, Kentaro Mizuhara, MD1*, Ayako Muramatsu, MD1*, Haruya Okamoto, MD1*, Yuka Kawaji-Kanayama1*, Yoko Katsuragawa-Taminishi, MD1*, Takahiro Fujino, MD, PhD1*, Taku Tsukamoto, MD, PhD1*, Shinsuke Mizutani, MD, PhD1*, Yuji Shimura, MD, PhD1*, Eiichi Konishi, MD, PhD2* and Junya Kuroda, MD, PhD1

1Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
2Department of Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Ted B. Piorczynski, PhD1*, Yun Kyoung Ryu, MD, PhD2, Manuel Pazos II, MS, BS2*, Wenxuan Huang2*, Seda S. Tolu, MD3, Brian Estrella, PhD2* and Jennifer E Amengual, MD4*

1Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY
2Division of Hematology and Oncology, Columbia University Irving Medical Center, New York
3Division of Hematology and Oncology, Columbia University Irving Medical Center, New York City, NY
4Lymphoma Program, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York

Christine A Herne, PhD1*, Jennifer E Bruno, BS2*, Andrea M Baran, MS3*, Derick R Peterson, PhD3*, Audrey H Chung1*, Tim R Mosmann, PhD2*, Sally A Quataert, PhD2*, Andrew G Evans, MD, PhD4*, Walter R Burack, MD, PhD4, Clive S Zent, MD1 and Charles C Chu, PhD1

1Wilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY
2Department of Microbiology and Immunology, Center for Vaccine Biology & Immunology, and Human Immunology Center, University of Rochester Medical Center, Rochester, NY
3Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY
4Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY

Metin Gunes, PhD1*, Steven T. Rosen, MD1 and Emine Gulsen Gunes, PhD1,2,3

1Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
3Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope National Medical Center, Duarte, CA

*signifies non-member of ASH